Dopamine transporter proline mutations influence dopamine uptake, cocaine analog recognition, and expression

FASEB Journal

Volumn 14, Issue 5, 2000, Pages 715-728

  Lin, Zhicheng ^a   Itokawa, Masanari ^a   Uhl, George R ^a,b  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Affinity; Ion gradients; Plasma membrane targeting; Translocation; Turnover rate

Indexed keywords

COCAINE; DOPAMINE; DOPAMINE TRANSPORTER;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CELLULAR DISTRIBUTION; DOPAMINE UPTAKE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION;

ANIMALIA; TRIXIS;

EID: 0034117176     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fasebj.14.5.715     Document Type: Article

References (33)

1. Woolverton, W. L., and Johnson, K. M. (1992) Neurobiology of cocaine abuse. Trends Pharmacol. Sci. 13, 193-200
2. Boja, J. W., Vaughan, R. A., Patel, A., Shaya, E., and Kuhar, M. J. (1994) The dopamine transporter. In Dopamine Receptors and transporters: Pharmacology. Structure, and Function (Niznik, H. B., ed) pp. 611-644, Marcel Dekker, New York
3. Witkin, J. M. (1994) Pharmacotherapy of cocaine abuse: preclinical development. Neurosci. Biobehav. Rev. 18, 121-142
4. Self, D. W., and Nestler, E. J. (1995) Molecular mechanisms of drug reinforcement and addiction. Annu. Rev. Neurosci. 18, 463-495
5. +: uptake and toxicity in nonneuronal COS cells expressing dopamine transporter cDNA. Ann. Neurol. 32, 109-111
6. Pifl, C., Giros, B., and Caron, M. G. (1993) Dopamine transporter expression confers cytotoxicity to low doses of the Parkinsonism-inducing neurotoxin 1-methyl-4-phenylpyridinium. J. Neurosci. 13, 4246-4253
7. Ritz, M. C., Lamb, R. J., Goldberg, S. R., and Kuhar, M. J. (1987) Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science 237, 1219-1223
8. Bergman, J., Madras, B. K., Johnson, S. E., and Spealman, R. D. (1989) Effects of cocaine and related drugs in nonhuman primates. III. Self-administration by squirrel monkeys. J. Pharmacol. Exp. Ther. 251, 150-155
9. Shimada, S., Kitayama, S., Lin, C.-L., Patel, A., Nanthankumar, E., Gregor, P., Kuhar, M., and Uhl, G. R. (1991) Cloning and expression of a cocaine-sensitive dopamine transporter complementary DNA. Science 254, 576-578
10. Kilty, J. E., Lorang, D., and Amara, S. G. (1991) Cloning and expression of a cocaine-sensitive rat dopamine transporter. Science 254, 578-579
11. Uhl, G. R., and Johnson, P. S. (1994) Neurotransmitter transporters: three important gene families for neuronal function. J. Exp. Biol. 196, 229-236
12. Giros, B., Wang, Y.-M., Suter, S., McLeskey, S. B., Pifl, C., and Caron, M. G. (1994) Delineation of discrete domains for substrate cocaine and tricyclic antidepressant interactions using chimeric dopamine-norepinephrine transporters. J. Biol. Chem. 269, 15985-15988
13. Buck, K. J., and Amara, S. G. (1994) Chimeric dopaminenorepinephrine transporters delineate structural domains influencing selectivity for catecholamines and 1-methyl-4-phenylpyridinium. Proc. Natl. Acad. Sci. USA 91, 12584-12588
14. Buck, K. J., and Amara, S. G. (1995) Structural domains of catecholamine transporter chimeras involved in selective inhibition by antidepressants and psychomotor stimulants. Mol. Pharmacol. 48, 1030-1037
15. Kitayama, S., Shimada, S., Xu, H., Markham, L., Donovan, D. M., and Uhl, G. R. (1992) Dopamine transporter site-directed mutations differentially alter substrate transport and cocaine binding. Proc. Natl. Acad. Sci. USA 89, 7782-7785
16. Rothschild, K. J., He, Y.-W., Gray, D., Roepe, P. D., Pelletier, S. L., Brown, R. S., and Herzfeld, J. (1989) Fourier transform infrared evidence for proline structural changes during the bacteriorhodopsin photocycle, Proc. Natl. Acad. Sci. USA 86, 9832-9835
17. Brandl, C. J., and Deber, C. M. (1986) Hypothesis about the function of membrane-buried proline residues in transport proteins. Proc. Natl. Acad. Sci. USA 83, 917-921
18. Chou, P. Y., and Fasman, G. D. (1978) Prediction of the secondary structure of proteins from their amino acid sequence. Adv. Enzymol. Relat. Areas Mol. Biol. 47, 45-148
19. Henderson, R., Baldwin, J. M., Ceska, T. A., Zemlin, F., Beckmann, E., and Downing, K. H. (1990) Model for the structure of bacteriorhodopsin based on high-resolution electron cryo-microscopy. J. Mol. Biol. 213, 899-929
20. Barlow, D. J., and Thornton, J. M. (1988) Helix geometry in proteins. J. Mol. Biol. 201, 601-619
21. Von Heijne, G. (1991) Proline kinks in transmembrane alpha-helices. J. Mol. Biol 218, 499-503
22. 2+-ATPase of sarcoplasmic reticulum. J. Biol. Chem. 264, 21024-21030
23. Sankara-Ramakrishnan, R., and Vishveshwara, S. (1989) A hydrogen bonded chain in bacteriorhodopsin by computer modeling approach. J. Biomol. Strut, Dyn. 7, 187-205
24. Richards, F. M. (1977) Areas, volumes, packing and protein structure. Annu. Rev. Biophys. Bioengin. 6, 151-176
25. Sansom, M. S. (1992) Proline residues in transmembrane helices of channel and transport proteins: a molecular modeling study. Protein Engin. 5, 53-60
26. Dunker, A. K. (1982) A proton motive force transducer and its role in proton pumps, proton engines, tobacco mosaic virus assembly and hemoglobin allosterism. J. Theor. Biol. 97, 95-127
27. Amara, S. G., and Kuhar, M. J. (1995) Neurotransmitter transporters: recent progress. Annu. Rev. Neurosci. 16, 73-93
28. Freed, C., Revay, R., Vaughan, R. A., Kriek, E., Grant, S., Uhl, G. R., and Kuhar, M. J. (1995) Dopamine transporter immunoreactivity in rat brain. J. Comp. Neurol. 359, 340-9
29. Vaughn, R., Uhl, G. R., and Kuhar, M. J. (1993) Recognition of dopamine transporters of antipeptide antibodies. Mol. Cell. Neurosci. 4, 209-215
30. Cheng, Y., and Prusoff, W. H. (1973) Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (150) of an enzymatic reaction. Biochem. Pharmacol. 22, 3099-108
31. Lin, Z., Wang, W., Kopajtic, T., Revay, R. S., and Uhl, G. R. (1999) Dopamine transporter: transmembrane phenylalanine mutations can selectively influence dopamine uptake and cocaine analog recognition. Mol. Pharmacol. 56, 434-447
32. Gunasekaran, K., Nagarajaram, H. A., Ramakrishnan, C., and Balaram, P. (1998) Stereochemical punctuation marks in protein structures: glycine and proline containing helix stop signals. J. Mol. Biol. 275, 917-32
33. Rassendren, F., Buell, G., Newbolt, A., North, R. A., and Surprenant, A. (1997) Identification of amino acid residues contributing to the pore of a P2X receptor. EMBO J. 16, 3446-54